481 related articles for article (PubMed ID: 29562940)
1. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis.
Yang X; Huang H; Zeng Z; Zhao L; Hu P; He D; Tang X; Zeng Z
Clin Biochem; 2013 Oct; 46(15):1377-82. PubMed ID: 23735602
[TBL] [Abstract][Full Text] [Related]
3. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
Aalami AH; Abdeahad H; Mesgari M; Sathyapalan T; Sahebkar A
Biomed Res Int; 2021; 2021():5557309. PubMed ID: 33997007
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
Xie Q; Huang Z; Zhu Z; Zheng X; Liu J; Zhang M; Zhang Y
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):38-44. PubMed ID: 27363065
[TBL] [Abstract][Full Text] [Related]
5. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
7. Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis.
Zhao L; Li J; Xue Z; Wang J
Clin Transl Oncol; 2024 Jun; 26(6):1497-1507. PubMed ID: 38227115
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
Wang Z; Wang X; Zhang D; Yu Y; Cai L; Zhang C
Tumour Biol; 2017 Jun; 39(6):1010428317709990. PubMed ID: 28639914
[TBL] [Abstract][Full Text] [Related]
10. ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis.
He H; Han C; Hao L; Zang G
Oncol Lett; 2016 Jul; 12(1):83-88. PubMed ID: 27347104
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis.
Cui X; Jing X; Long C; Yi Q; Tian J; Zhu J
Oncotarget; 2017 May; 8(21):35222-35233. PubMed ID: 28415640
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
13. Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
Cheng Y; Deng X; Yang X; Li P; Zhang X; Li P; Tao J; Lu Q; Wang Z
Onco Targets Ther; 2015; 8():2089-96. PubMed ID: 26316777
[TBL] [Abstract][Full Text] [Related]
14. Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
Arnold SA; Loomans HA; Ketova T; Andl CD; Clark PE; Zijlstra A
Clin Exp Metastasis; 2016 Jan; 33(1):29-44. PubMed ID: 26456754
[TBL] [Abstract][Full Text] [Related]
15. Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review.
Ku JH; Godoy G; Amiel GE; Lerner SP
BJU Int; 2012 Sep; 110(5):630-6. PubMed ID: 22353238
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
Xia Y; Liu YL; Yang KH; Chen W
Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
Mi Y; Zhao Y; Shi F; Zhang M; Wang C; Liu X
Asia Pac J Clin Oncol; 2019 Apr; 15(2):e11-e19. PubMed ID: 29931834
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
Ye Q; Wang J; Xu D; Liu Y; Zhang D; Ye J; Li H
Expert Rev Anticancer Ther; 2022 Dec; 22(12):1357-1369. PubMed ID: 36374119
[TBL] [Abstract][Full Text] [Related]
19. Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
Wang J; Gao Y; Wang X; Gao Y; Li L; Zhang J; Zhang L; Che F
Int J Biol Markers; 2020 Jun; 35(2):40-48. PubMed ID: 32460591
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
Xiao S; Wang J; Xiao N
Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
